nRichDX, Shaun Sanders, Investor Relations Advisor

An emerging leader in the liquid biopsy sample prep market, delivering to downstream molecular testing up to 75X more target material (ctDNA, CTCs, exosomes, etc.) than existing sample prep systems.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Shaun Sanders
Shaun Sanders
Investor Relations Advisor, nRichDX